Patent · US Expired

Antitumor compounds

US5571822A · kind A · utility

7Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 30, 1994
Grant dateNov 5, 1996
Priority date
Expiry dateSep 30, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/5377
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of inhibiting tumor-cell growth in a mammalian subject, by administering a therapeutically effective amount of a selected 2-phenyl-4-quinolone compound. The selected compound shows unexpectely high activity against a variety of solid tumor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.